Single-Port Insulin Infusion for Improved Diabetes Management

SPIDIMAN Banner ID 62

Overview

JOANNEUM RESEARCH´s HEALTH – Institute for Biomedicine and Health Sciences will coordinate the SPIDIMAN project with a total budget of almost € 6.4 mio. The project started on November 1, 2012 and will last for 5 years.

The project will exploit a novel glucose-sensor technology that has been developed as part of the national project i-Cath, funded by the BMVIT. The consortium will develop a new coating technology to apply a glucose-sensitive luminescent dye onto a standard insulin infusion catheter. This integrated glucose sensor will then be incorporated into a single-port artificial pancreas system. The system will utilize advanced optical continuous glucose monitoring technology (smart tattoos) with improved sensor accuracy, faster response times, a wider dynamic range and higher signal stability, which will improve diabetes management by reducing hypo- and hyperglycaemic episodes.

Role of the BioNanoNet Forschungsgesellschaft mbH in the “SPIDIMAN” project:

Within “SPIDIMAN”, the BioNanoNet Forschungsgesellschaft mbH is responsible for the day-to-day management of the whole project. As a part of the Project Management Team, it supports the Project Coordinator in all administrative issues as well as dissemination activities.

For more details please visit the project website http://www.spidiman.eu/